Cancer Research Landon Prizes for Basic and Translational Cancer Research  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 52, 2951-2956, May 15, 1992]
© 1992 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Benzil, D. L.
Right arrow Articles by Finch, P. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Benzil, D. L.
Right arrow Articles by Finch, P. W.

Expression Pattern of {alpha}-Protein Kinase C in Human Astrocytomas Indicates a Role in Malignant Progression

Deborah L. Benzil1, Sydney D. Finkelstein, Mel H. Epstein and Paul W. Finch2

Program in Neurosurgery, Departments of Clinical Neurosciences [D. L. B., M. H. E., P. W. F.] and Surgical Pathology [S. D. F.], Brown University and Rhode Island Hospital, Providence, Rhode Island 02903

Protein kinase C (PKC) is a family of isoenzymes which play an important role in regulating cell proliferation and differentiation. Constitutive activation of PKC, either by phorbol esters or overexpression of specific isoenzymes, leads to growth abnormalities in vitro and tumor promotion in vivo. Since stimulation of PKC in cultured astrocytes results in biochemical and morphological alterations associated with the transformed phenotype, we wanted to determine whether abnormal expression of specific isoenzymes of PKC was important in development of human astrocytomas in vivo.

We have detected a specific pattern of {alpha}-PKC expression in human astrocytomas which is noteworthy because the highest transcript levels were detected in well-differentiated (Grade 1) tumors, with intermediate expression in anaplastic (Grade 2) astrocytomas and low or nondetectable levels in glioblastomas (Grade 3 astrocytomas) and normal controls. In comparison, the ß-PKC transcript was not detected in any of the tumors, while the {gamma}-PKC transcript was present in only one Grade 2 tumor. Immunohistochemistry, using a monoclonal antibody to {alpha}-PKC, revealed diffuse, positive cytoplasmic signals in most cells of the Grade 1 tumors. Grade 2 tumors exhibited heterogeneity of {alpha}-PKC expression, although a significant percentage of cells showed positivity. In contrast, only a small number of differentiated cells within Grade 3 tumors were positive for {alpha}-PKC expression, with the more malignant, dedifferentiated cells uniformly negative. Throughout all tumor grades, the staining pattern of {alpha}-PKC closely paralleled that of glial fibrillary acidic protein.

Taken in conjunction with the established role of PKC in tumor promotion, these results suggest that the {alpha}-PKC isoenzyme plays a specific role in facilitating clonal expansion of transformed astrocytes in low-grade astrocytomas. Analysis of {alpha}-PKC may therefore serve as a direct biological marker of malignancy which may serve to enhance the current histopathological grading system.

1 Recipient of the Anthony Greto Fellowship from the Association for Brain Tumor Research.

2 To whom requests for reprints should be addressed, at Department of Clinical Neurosciences, Rhode Island Hospital, Aldrich 516, 593 Eddy Street, Providence, RI 02903.

Received 9/11/91. Accepted 3/10/92.




This article has been cited by other articles:


Home page
JCOHome page
D. J. Propper, A. C. McDonald, A. Man, P. Thavasu, F. Balkwill, J. P. Braybrooke, F. Caponigro, P. Graf, C. Dutreix, R. Blackie, et al.
Phase I and Pharmacokinetic Study of PKC412, an Inhibitor of Protein Kinase C
J. Clin. Oncol., March 1, 2001; 19(5): 1485 - 1492.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
M. J. Clemens, I. Trayner, and J. Menaya
The role of protein kinase C isoenzymes in the regulation of cell proliferation and differentiation
J. Cell Sci., December 1, 1992; 103(4): 881 - 887.
[PDF]


Home page
J. Biol. Chem.Home page
I. M. Hussaini, L. R. Karns, G. Vinton, J. E. Carpenter, G. T. Redpath, J. J. Sando, and S. R. VandenBerg
Phorbol 12-Myristate 13-Acetate Induces Protein Kinase Ceta -specific Proliferative Response in Astrocytic Tumor Cells
J. Biol. Chem., July 14, 2000; 275(29): 22348 - 22354.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1992 by the American Association for Cancer Research.